BridgeBio Pharma (BBIO) PT Raised to $106 at Mizuho

March 18, 2026 3:35 PM

Mizuho analyst Salim Syed raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $106.00 (from $91.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found